• Airnov innovations help maximise oxygen protection in pharmaceutical and nutraceutical products.
    Airnov innovations help maximise oxygen protection in pharmaceutical and nutraceutical products.
Close×

Airnov Healthcare Packaging, global developer of controlled atmosphere packaging, is enabling manufacturers of pharmaceutical and nutraceutical products to optimise their product development cycles through its series of oxygen protection and simulation solutions.

Products in these categories are often oxygen sensitive and require protective packaging. This includes drugs, probiotics, proteins, stents, surgical products, devices, and various dry products.

To protect such vital commodities, Airnov offers two key solutions – Oxynov Barrier Bottles and Pharmakeep.

Oxynov barrier bottles utilise extrusion-blow-molding (EBM) technology, creating a six-layer bottle with ethylene vinyl alcohol (EVOH), which according to Airnov, offers the highest barrier to oxygen and moisture available on the market within this packaging category.

Further, these are rigid bottles do not shrink when using oxygen absorbers, which the company says offers a superior outcome to alternative standard LDPE and HDPE bottles.

Pharmakeep is a two-in-one oxygen and moisture absorber, available in drop-in canisters and packets. It helps to simplify the protection process and offers a fast way of absorbing oxygen inside the headspace of the packaging versus iron oxygen absorbers.

Oxygen concentrations are reduced from 20.8 per cent to less than 0.01 per cent, avoiding the use of nitrogen flushing.

Airnov also offers a global evaluation tool for oxygen protection through its Stablus predictive simulator. Stablus helps to reduce time spent on product development in relation to the selection of appropriate protective solutions.

“We are encouraging our customers to evaluate oxygen protection with Stablus at the start of their product development projects to help optimise oxygen protection, taking into account the key criteria of a drug product such as moisture content, packaging performance, climactic conditions, and shelf-life,” says Stephane Rault, oxygen absorber product manager, Airnov.

“If you’re looking to reduce your development time and costs, please contact Airnox for a full oxygen protection evaluation.”

Airnov’s Oxynov barrier bottles and Pharmakeep oxygen absorbers are widely available in different specifications, the company’s development team on hand to provide Stablus services throughout various regions.

Oxynov and Pharmakeep are available in the Australian market via Airnov Australia. For more information, contact the company's sales team.

Food & Drink Business

Inghams has placed its Western Australian farms and processing operations into complete lockdown after authorities confirmed Australia’s first detection of the high pathogenicity H5 avian influenza strain that has spread globally since 2020.

The a2 Milk Company is set to return $300 million to shareholders after securing Chinese regulatory approval that finalises its acquisition of the a2 Pokeno infant formula facility in New Zealand.

Seedlab Australia has appointed Kenna MacTavish as managing director, with co-founder Dr Hazel MacTavish-West stepping back from the chief executive role to become finance director and mentor.